2024-512152-38-00
Not yet recruiting
Phase 1/2
Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response - MIBIOTIMI
Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela1 site in 1 country100 target enrollmentNovember 15, 2024
Overview
- Phase
- Phase 1/2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela
- Enrollment
- 100
- Locations
- 1
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Virginia Pubul Núñez
Scientific
Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Characterisation of tumour heterogeneity and identification of adaptive resistance mechanisms of metastatic castration-resistant prostate carcinomaC61Malignant neoplasm of prostateDRKS00028021Klinik für Nuklearmedizin am Universitätsklinikum Augsburg45
Unknown
Not Applicable
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastasesSCLC niet kleincellig longcarcinoom, longkankerlungcancer, tumour heterogeneity, tumor heterogeniteit, CTC, circulating tumour cell, circulerende tumor celNL-OMON29203niversity Medical Centre Groningen30
Not yet recruiting
Not Applicable
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and its metastaseslungcancer1002765510029107NL-OMON45251niversitair Medisch Centrum Groningen50
Completed
Not Applicable
An integrated multi-omics study of tumor heterogeneity in patients with treatment-resistant malignant cancermalignant cancerJPRN-UMIN000040181Kansai Electric Power Hospital100
Not yet recruiting
Not Applicable
Fluorodeoxyglucose (FDG) and human epidermal growth factor receptor 2 (HER2) positron emission tomography (PET) scan in breast cancerBreast cancerCancer - BreastACTRN12624000918527Fiona Stanley Hospital10